Table 2 Prevalence of anogenital warts
From: Systematic review of the incidence and prevalence of genital warts
Study | Country / year | Population, setting and age groups | Prevalence % | ||
|---|---|---|---|---|---|
| Â | Â | Â | Males | Females | Overall |
Data based on retrospective administrative databases or medical chart reviews | |||||
Marra et al., 2009 [32] | Canada (British Columbia) / 2006 | Setting: physicians, hospitals and STI clinics (province-wide) | 0.16 | 0.14 | 0.15 |
Denominator: general population | |||||
Age: all ages | |||||
Kliewer et al., 2009 [33] | Canada (Manitoba) / 2004 | Setting: physician offices and hospitals (province-wide) | 0.17 | 0.13 | 0.15 |
Population: general population | |||||
Age: all ages | |||||
Vittori et al., 2008 [28] | Italy / 2005 | Setting: random sample of 78 gynecologists stratified by geographic region | NA | 0.6 | NA |
Population: female population visiting gynecologists | |||||
Age: 14–64 years | |||||
Castellsague et al., 2009 [29] | Spain / 2005 | Setting: representative sample of dermatologists, gynecologists and urologists in the public healthcare setting from 6 autonomous regions | 0.20 | 0.16 | 0.18 |
Population: general population (68% of total Spanish population) | |||||
Age: 14–64 years | |||||
Data based on prospectively collected physician reports | |||||
Mariani et al., 2011 [47] | Italy / 2010 | Setting: 45 extra-hospital gynecologists in gynecological ambulatories stratified by geographic region | NA | 0.56 | NA |
Population: female population listed with the above GPs (N = 16,410) | |||||
Age: 15–64 years | |||||
Pasciullo et al., 2011 [41] | Italy / 2009 | Setting: geographically representative sample of 650 GPs | 0.06 | 0.03 | 0.05 |
Population: population listed with the above GPs (N = 959,778) | |||||
Age: ≥15 years | |||||
Lee et al., 2010 [46] | South Korea / 2008 | Setting: gynecological clinics in the top 6 metropolitan cities | NA | 0.14 | NA |
Population: female patients visiting the above gynecological clinics (N = 117,381) | |||||
Age: all ages | |||||
Data based on genital examinations of samples from the general population | |||||
Sellors et al., 2000 [48] | Canada (Ontario) / 1998-1999 | Setting: family practices for cytologic screening randomly selected in proportion to the regional population | NA | 1.10 | NA |
Population: female population attending cervical Pap screening with the above family physicians (N = 909) | |||||
Age: 15–49 years | |||||
Nyári et al., 2004 [49] | Hungary (Southeast) / 2000 | Setting: outpatient gynecology clinics | NA | 4.03 | NA |
Population: randomly selected asymptomatic female population attending the above gynecology clinics (N = 397) | |||||
Age: mean 35.5 years (SD 9.7) | |||||
Jimenez-Vieyra, 2010 [50] | Mexico (Mexico City) / 2002–09 | Setting: sexual health clinic | NA | 3.20 | NA |
Population: female population attending opportunistic cervical Pap screening at above sexual health clinic (N = 3,232*) | |||||
Age: 15–54 years | |||||
Vaccarella et al., 2006 [45] | Mexico / 2003-2004 | Setting: 27 public clinics stratified by geographic region | 5.1†| NA | NA |
Population: male population seeking vasectomy in the above clinics (N = 779) | |||||
Age: mean 34.0 years | |||||
Garcia et al., 2004 [51] | Peru / 1997-98 | Setting: CBOs (mother’s clubs) from 18 districts | NA | 2.40 | NA |
Population: rural female population from the above mother’s clubs (N = 752) | |||||
Age: 18–67 years | |||||
Nyitray et al., 2008 [44] | USA (Tucson and Tampa) / NA | Setting: prospective HPV epidemiology study | 4.10 | NA | NA |
Population: heterosexual men from general population participating in the above study (N = 222) | |||||
Age: 18–40 years | |||||
Lan et al., 2008 [52] | Vietnam (Bavi district) / 2006 | Setting: gynecological examinations performed by physicians | NA | 0.20 | NA |
Population: married rural women randomly recruited from the general population (N = 1,012) | |||||
|  |  | Age: 18–49 years |  |  |  |